# Study of a New Catheter Using Force Sensing Capabilities for the Treatment of Atrial Fibrillation and Ventricular Tachycardia

> **NCT01032317** · PHASE1,PHASE2 · COMPLETED · sponsor: **Biosense Webster, Inc.** · enrollment: 22 (actual)

## Conditions studied

- Atrial Fibrillation
- Ischemic Ventricular Tachycardia

## Interventions

- **DEVICE:** Radiofrequency Catheter Ablation

## Key facts

- **NCT ID:** NCT01032317
- **Lead sponsor:** Biosense Webster, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-11
- **Primary completion:** 2010-11
- **Final completion:** 2010-11
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2014-12-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01032317

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01032317, "Study of a New Catheter Using Force Sensing Capabilities for the Treatment of Atrial Fibrillation and Ventricular Tachycardia". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT01032317. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*